CJC-1295 & Ipamorelin

CJC-1295 With and Without DAC

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-234 cited sources

The short answer

The DAC form carries a maleimidopropionic acid linker binding covalently to cysteine-34 of serum albumin, extending half-life to days. Without it (Modified GRF (1-29)), clearance takes about thirty minutes. The two differ by 279.3 Da, and that mass is the reliable discriminator.

Key facts

With DAC
3647.2 Da, CID 91971820
Without DAC
3367.9 Da, CID 56841945
Mass difference
279.3 Da (the linker)
DAC chemistry
Maleimide to albumin Cys34
With DAC half-life
Days
Without DAC half-life
~30 minutes
Other name for non-DAC
Modified GRF (1-29)

What DAC actually is

Drug Affinity Complex is ConjuChem's name for a maleimidopropionic acid group attached to the peptide. Maleimide reacts specifically with free thiols, and serum albumin has one: cysteine-34, the only free cysteine in the molecule. The result is a covalent bond, not the reversible association that fatty-acid conjugation produces in semaglutide.

Why covalent differs from reversible

This is the mechanistically interesting part. Semaglutide's fatty acid binds albumin reversibly, so a small free fraction is always available to act while the bound pool acts as a depot. DAC forms a permanent bond, so the peptide is attached to albumin for that albumin molecule's lifetime, and albumin's half-life is around nineteen days. The peptide's duration therefore tracks the carrier's, which is a different pharmacokinetic model entirely.

Research material referenced

CJC-1295 + Ipamorelin 5+5mg, third-party HPLC tested

Buy CJC-1295 + Ipamorelin · £42.99

The consequence for GH release

GHRH normally acts in pulses, and pituitary GH release is pulsatile. A compound producing continuous receptor stimulation is a different physiological stimulus from one producing brief pulses. Ionescu and Frohman examined this directly, reporting in the Journal of Clinical Endocrinology and Metabolism in 2006 that pulsatile GH secretion persists during continuous stimulation. The finding is relevant to what a long-acting GHRH analogue actually does.

How to tell which you have

Mass spectrometry. 3647.2 and 3367.9 are 279.3 apart, which is unambiguous on any instrument. Names are unreliable here because PubChem itself carries both 'with DAC' and 'no DAC' synonyms on a single record, and suppliers inherit that. A certificate stating a mass near 3368 describes the DAC-free peptide whatever the label says.

Which is used with ipamorelin

The non-DAC form is the more common pairing, on the reasoning that both compounds are then short-acting and produce a coordinated pulse rather than one brief and one sustained signal. That is a design rationale rather than a demonstrated advantage.

Quick reference

With DACWithout DAC (Mod GRF 1-29)
Molecular weight3647.2 Da3367.9 Da
PubChem CID9197182056841945
Albumin bindingCovalent, via Cys34None
Half-lifeDays~30 minutes
Stimulation patternContinuousPulsatile

Frequently asked questions

How much mass does DAC add?

279.3 Da. With DAC is 3647.2; without is 3367.9.

Is DAC binding reversible like semaglutide's?

No. Maleimide forms a covalent bond to albumin's Cys34, so the peptide stays attached for that albumin molecule's lifetime. Semaglutide's fatty acid binds reversibly.

How do I tell the forms apart?

By mass. Names are unreliable because PubChem carries contradictory synonyms on one record.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More CJC-1295 & Ipamorelin articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.